Bristol-Myers Squibb (BMY) stock forecast for 2025. Forecast tables and graphs.

Bristol-Myers Squibb (BMY) stock forecast for 2025

The forecast has been updated: August 4, 2021 5:52


Bristol-Myers stock price online today

Analyst Target Price

75.37

Dividend Date

02.08.2021

Ex Dividend Date

01.07.2021

Last Split Factor

1000000:95

Last Split Date

07.08.2001

Should you buy or sell Bristol-Myers stock stock today? What is the projected target price level for 2025? How much will it cost in 2025? Bristol-Myers stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2025.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $75.37 target price for Bristol-Myers stock stock.

Today 200 Day Moving Average is the support level (64.35 $).

50 Day Moving Average is the support level (67.09 $).




BMY Forecast for 2025

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 80.25 78.88 81.39 3.09 %
Feb 78.26 74.90 81.70 8.32 %
Mar 77.83 76.63 79.41 3.50 %
Apr 76.33 74.78 77.88 3.99 %
May 79.61 77.59 81.79 5.14 %
Jun 77.64 75.63 80.11 5.60 %
Jul 80.28 78.25 81.39 3.85 %
Aug 81.39 78.84 82.64 4.60 %
Sep 81.21 79.96 84.07 4.89 %
Oct 82.68 81.00 83.68 3.21 %
Nov 83.45 80.79 86.71 6.83 %
Dec 82.40 79.32 85.71 7.46 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Bristol-Myers stock.


Bristol-Myers overview

Bristol-Myers Address

430 E. 29TH STREET, 14 FLOOR, NEW YORK, NY, US

Market Capitalization

154 014 433 000 $

EBITDA

18 836 001 000

PE Ratio

None

PEG Ratio

32.24

Dividend Per Share

1.92

Dividend Yield

0.0282

EPS

-2.274

Quarterly Earnings Growth YOY

-0.011

Quarterly Revenue Growth YOY

0.155

Trailing PE

0

Forward PE

9.03

EV To Revenue

4.139

EV To EBITDA

22.97

52 Week High

69.33

52 Week Low

55.19

50 Day Moving Average

67.09

200 Day Moving Average

64.35

Shares Outstanding

2222110000

Shares Float

2187871000

Shares Short Prior Month

20791300

Short Ratio

2.1

Percent Insiders

0.068

Percent Institutions

75.21

Bristol-Myers stock forecast for this year


Bristol-Myers stock forecast for Jan 2025.
Estimated Average Forecasted Bristol-Myers Price: 80.25. Negative monthly dynamics of the instrument is expected with 3.091% volatility is expected.

Pessimistic forecast: 78.88

Optimistic: 81.39


Bristol-Myers stock forecast for Feb 2025.
Estimated Average Forecasted Bristol-Myers Price: 78.26. Negative monthly dynamics of the instrument is expected with 8.324% volatility is expected.

Pessimistic forecast: 74.90

Optimistic: 81.70


Bristol-Myers stock forecast for Mar 2025.
Estimated Average Forecasted Bristol-Myers Price: 77.83. Negative monthly dynamics of the instrument is expected with 3.504% volatility is expected.

Pessimistic forecast: 76.63

Optimistic: 79.41


Bristol-Myers stock forecast for Apr 2025.
Estimated Average Forecasted Bristol-Myers Price: 76.33. Negative monthly dynamics of the instrument is expected with 3.989% volatility is expected.

Pessimistic forecast: 74.78

Optimistic: 77.88


Bristol-Myers stock forecast for May 2025.
Estimated Average Forecasted Bristol-Myers Price: 79.61. Positive monthly dynamics of the instrument is expected with 5.139% volatility is expected.

Pessimistic forecast: 77.59

Optimistic: 81.79


Bristol-Myers stock forecast for Jun 2025.
Estimated Average Forecasted Bristol-Myers Price: 77.64. Negative monthly dynamics of the instrument is expected with 5.596% volatility is expected.

Pessimistic forecast: 75.63

Optimistic: 80.11


Bristol-Myers stock forecast for Jul 2025.
Estimated Average Forecasted Bristol-Myers Price: 80.28. Positive monthly dynamics of the instrument is expected with 3.852% volatility is expected.

Pessimistic forecast: 78.25

Optimistic: 81.39


Bristol-Myers stock forecast for Aug 2025.
Estimated Average Forecasted Bristol-Myers Price: 81.39. Positive monthly dynamics of the instrument is expected with 4.604% volatility is expected.

Pessimistic forecast: 78.84

Optimistic: 82.64


Bristol-Myers stock forecast for Sep 2025.
Estimated Average Forecasted Bristol-Myers Price: 81.21. Negative monthly dynamics of the instrument is expected with 4.888% volatility is expected.

Pessimistic forecast: 79.96

Optimistic: 84.07


Bristol-Myers stock forecast for Oct 2025.
Estimated Average Forecasted Bristol-Myers Price: 82.68. Positive monthly dynamics of the instrument is expected with 3.206% volatility is expected.

Pessimistic forecast: 81.00

Optimistic: 83.68


Bristol-Myers stock forecast for Nov 2025.
Estimated Average Forecasted Bristol-Myers Price: 83.45. Positive monthly dynamics of the instrument is expected with 6.828% volatility is expected.

Pessimistic forecast: 80.79

Optimistic: 86.71


Bristol-Myers stock forecast for Dec 2025.
Estimated Average Forecasted Bristol-Myers Price: 82.40. Negative monthly dynamics of the instrument is expected with 7.456% volatility is expected.

Pessimistic forecast: 79.32

Optimistic: 85.71



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 121.57 (04.08.2021) -0.45 %
AbbVie Inc.
ABBV 115.08 (04.08.2021) -1.01 %
Aeterna Zentaris Inc.
AEZS 0.7001 (04.08.2021) -1.86 %
Allakos Inc.
ALLK 79.93 (04.08.2021) 2.49 %
Allogene Therapeutics, Inc.
ALLO 22.13 (04.08.2021) 0.91 %
Amgen Inc.
AMGN 228.31 (04.08.2021) -6.46 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 12.4 (04.08.2021) -1.51 %
Aurora Cannabis Inc.
ACB 6.93 (04.08.2021) -3.62 %
Becton Dickinson and Company
BDX 254.74 (04.08.2021) -0.40 %
Biogen Inc.
BIIB 338.1 (04.08.2021) 0.03 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 123.36 (04.08.2021) 3.86 %
BioNTech SE
BNTX 414.44 (04.08.2021) 17.80 %
bluebird bio, Inc.
BLUE 25 (04.08.2021) -0.44 %
Boston Scientific Corp.
BSX 44.26 (04.08.2021) -2.81 %
Bristol-Myers Squibb Company
BMY 68.49 (04.08.2021) -1.18 %
Canopy Growth Corp.
CGC 18.28 (04.08.2021) -2.61 %
Castle Biosciences, Inc.
CSTL 69.19 (04.08.2021) -1.68 %
Eli Lilly and Company
LLY 262.47 (04.08.2021) 2.53 %
Emergent BioSolutions Inc.
EBS 62.04 (04.08.2021) -2.11 %
Exelixis, Inc.
EXEL 16.79 (04.08.2021) -1.06 %
G1 Therapeutics, Inc.
GTHX 16.72 (04.08.2021) -0.59 %
Gilead Sciences, Inc.
GILD 69.24 (04.08.2021) -0.84 %
GlaxoSmithKline plc
GSK 40.5 (04.08.2021) -0.34 %
GoodRx Holdings, Inc.
GDRX 31.78 (04.08.2021) 0.44 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 77.34 (04.08.2021) -0.78 %
Inovio Pharmaceuticals, Inc.
INO 8.76 (04.08.2021) 1.74 %
Johnson & Johnson
JNJ 173.36 (04.08.2021) -0.59 %
Medtronic plc.
MDT 128.38 (04.08.2021) -2.34 %
Merck & Co., Inc.
MRK 75.48 (04.08.2021) -1.22 %
Moderna, Inc.
MRNA 419.05 (04.08.2021) 8.42 %
Novartis AG
NVS 91.59 (04.08.2021) -1.21 %
Novavax, Inc.
NVAX 223.81 (04.08.2021) 18.69 %
ObsEva SA
OBSV 2.49 (04.08.2021) -0.40 %
OrganiGram Holdings Inc.
OGI 2.49 (04.08.2021) -3.49 %
Pfizer Inc.
PFE 45.19 (04.08.2021) -1.07 %
Regeneron Pharmaceuticals, Inc.
REGN 580.95 (04.08.2021) -0.95 %
Sanofi
SNY 49.88 (04.08.2021) -3.15 %
Schrodinger, Inc.
SDGR 68.43 (04.08.2021) 3.06 %
Senseonics Holdings, Inc.
SENS 3.03 (04.08.2021) -1.94 %
Sorrento Therapeutics, Inc.
SRNE 8.23 (04.08.2021) 0.49 %
Stryker Corp.
SYK 262.58 (04.08.2021) -2.03 %
Sundial Growers Inc.
SNDL 0.7811 (04.08.2021) -4.21 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 10 (04.08.2021) 0.81 %
Thermo Fisher Scientific Inc.
TMO 538.88 (04.08.2021) 0.35 %
Tilray, Inc.
TLRY 13.96 (04.08.2021) -2.04 %
UnitedHealth Group, Inc.
UNH 421.54 (04.08.2021) -0.09 %
Veeva Systems Inc.
VEEV 340.98 (04.08.2021) 0.87 %
Zomedica Corp.
ZOM 0.578 (04.08.2021) -4.73 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.33 (04.08.2021) -2.48 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.